Computational Drug Repositioning Using Similarity Constrained Weight Regularization Matrix Factorization: A Case of COVID-19

Overview

Journal J Cell Mol Med

Specialties Cell Biology
Molecular Biology

Date 2022 Jun 1

PMID 35644992

Authors

Junlin Xu

Yajie Meng

Lihong Peng

Lijun Cai

Xianfang Tang

Yuebin Liang

Geng Tian

Jialiang Yang

Affiliations

Soon will be listed here.

Abstract

Amid the COVID-19 crisis, we put sizeable efforts to collect a high number of experimentally validated drug-virus association entries from literature by text mining and built a human drug-virus association database. To the best of our knowledge, it is the largest publicly available drug-virus database so far. Next, we develop a novel weight regularization matrix factorization approach, termed WRMF, for in silico drug repurposing by integrating three networks: the known drug-virus association network, the drug-drug chemical structure similarity network, and the virus-virus genomic sequencing similarity network. Specifically, WRMF adds a weight to each training sample for reducing the influence of negative samples (i.e. the drug-virus association is unassociated). A comparison on the curated drug-virus database shows that WRMF performs better than a few state-of-the-art methods. In addition, we selected the other two different public datasets (i.e. Cdataset and HMDD V2.0) to assess WRMF's performance. The case study also demonstrated the accuracy and reliability of WRMF to infer potential drugs for the novel virus. In summary, we offer a useful tool including a novel drug-virus association database and a powerful method WRMF to repurpose potential drugs for new viruses.

Citing Articles

A deep drug prediction framework for viral infectious diseases using an optimizer-based ensemble of convolutional neural network: COVID-19 as a case study.

Aruna A, Babu K, Deepthi K Mol Divers. 2024; .

PMID: 39379663 DOI: 10.1007/s11030-024-11003-7.

A comparative benchmarking and evaluation framework for heterogeneous network-based drug repositioning methods.

Li Y, Yang Y, Tong Z, Wang Y, Mi Q, Bai M Brief Bioinform. 2024; 25(3).

PMID: 38647153 PMC: 11033846. DOI: 10.1093/bib/bbae172.

Drug repositioning based on weighted local information augmented graph neural network.

Meng Y, Wang Y, Xu J, Lu C, Tang X, Peng T Brief Bioinform. 2023; 25(1).

PMID: 38019732 PMC: 10686358. DOI: 10.1093/bib/bbad431.

A review of SARS-CoV-2 drug repurposing: databases and machine learning models.

Elkashlan M, Ahmad R, Hajar M, Al Jasmi F, Corchado J, Nasarudin N Front Pharmacol. 2023; 14:1182465.

PMID: 37601065 PMC: 10436567. DOI: 10.3389/fphar.2023.1182465.

Guiding Drug Repositioning for Cancers Based on Drug Similarity Networks.

Qin S, Li W, Yu H, Xu M, Li C, Fu L Int J Mol Sci. 2023; 24(3).

PMID: 36768566 PMC: 9917231. DOI: 10.3390/ijms24032244.

References

Yang M, Wu G, Zhao Q, Li Y, Wang J . Computational drug repositioning based on multi-similarities bilinear matrix factorization. Brief Bioinform. 2020; 22(4). DOI: 10.1093/bib/bbaa267. View

Wang M, Cao R, Zhang L, Yang X, Liu J, Xu M . Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. Cell Res. 2020; 30(3):269-271. PMC: 7054408. DOI: 10.1038/s41422-020-0282-0. View

Davis A, Grondin C, Johnson R, Sciaky D, Wiegers J, Wiegers T . Comparative Toxicogenomics Database (CTD): update 2021. Nucleic Acids Res. 2020; 49(D1):D1138-D1143. PMC: 7779006. DOI: 10.1093/nar/gkaa891. View

Mongia A, Saha S, Chouzenoux E, Majumdar A . A computational approach to aid clinicians in selecting anti-viral drugs for COVID-19 trials. Sci Rep. 2021; 11(1):9047. PMC: 8079380. DOI: 10.1038/s41598-021-88153-3. View

Zumla A, Chan J, Azhar E, Hui D, Yuen K . Coronaviruses - drug discovery and therapeutic options. Nat Rev Drug Discov. 2016; 15(5):327-47. PMC: 7097181. DOI: 10.1038/nrd.2015.37. View

Meng Y, Jin M, Tang X, Xu J . Drug repositioning based on similarity constrained probabilistic matrix factorization: COVID-19 as a case study. Appl Soft Comput. 2021; 103:107135. PMC: 7825831. DOI: 10.1016/j.asoc.2021.107135. View

Guan N, Zhao Y, Wang C, Li J, Chen X, Piao X . Anticancer Drug Response Prediction in Cell Lines Using Weighted Graph Regularized Matrix Factorization. Mol Ther Nucleic Acids. 2019; 17:164-174. PMC: 6610642. DOI: 10.1016/j.omtn.2019.05.017. View

Luo H, Wang J, Li M, Luo J, Peng X, Wu F . Drug repositioning based on comprehensive similarity measures and Bi-Random walk algorithm. Bioinformatics. 2016; 32(17):2664-71. DOI: 10.1093/bioinformatics/btw228. View

Chen X, Li S, Yin J, Wang C . Potential miRNA-disease association prediction based on kernelized Bayesian matrix factorization. Genomics. 2019; 112(1):809-819. DOI: 10.1016/j.ygeno.2019.05.021. View

10.

de Wit E, van Doremalen N, Falzarano D, Munster V . SARS and MERS: recent insights into emerging coronaviruses. Nat Rev Microbiol. 2016; 14(8):523-34. PMC: 7097822. DOI: 10.1038/nrmicro.2016.81. View

11.

Zeng X, Zhu S, Liu X, Zhou Y, Nussinov R, Cheng F . deepDR: a network-based deep learning approach to in silico drug repositioning. Bioinformatics. 2019; 35(24):5191-5198. PMC: 6954645. DOI: 10.1093/bioinformatics/btz418. View

12.

Iorio F, Bosotti R, Scacheri E, Belcastro V, Mithbaokar P, Ferriero R . Discovery of drug mode of action and drug repositioning from transcriptional responses. Proc Natl Acad Sci U S A. 2010; 107(33):14621-6. PMC: 2930479. DOI: 10.1073/pnas.1000138107. View

13.

Zhang W, Chen Y, Li D, Yue X . Manifold regularized matrix factorization for drug-drug interaction prediction. J Biomed Inform. 2018; 88:90-97. DOI: 10.1016/j.jbi.2018.11.005. View

14.

Katoh K, Kuma K, Toh H, Miyata T . MAFFT version 5: improvement in accuracy of multiple sequence alignment. Nucleic Acids Res. 2005; 33(2):511-8. PMC: 548345. DOI: 10.1093/nar/gki198. View

15.

Xu J, Meng Y, Peng L, Cai L, Tang X, Liang Y . Computational drug repositioning using similarity constrained weight regularization matrix factorization: A case of COVID-19. J Cell Mol Med. 2022; 26(13):3772-3782. PMC: 9258716. DOI: 10.1111/jcmm.17412. View

16.

Saberian N, Peyvandipour A, Donato M, Ansari S, Draghici S . A new computational drug repurposing method using established disease-drug pair knowledge. Bioinformatics. 2019; 35(19):3672-3678. PMC: 6761937. DOI: 10.1093/bioinformatics/btz156. View

17.

Martinez V, Navarro C, Cano C, Fajardo W, Blanco A . DrugNet: network-based drug-disease prioritization by integrating heterogeneous data. Artif Intell Med. 2015; 63(1):41-9. DOI: 10.1016/j.artmed.2014.11.003. View

18.

Draghici S, Nguyen T, Sonna L, Ziraldo C, Vanciu R, Fadel R . COVID-19: disease pathways and gene expression changes predict methylprednisolone can improve outcome in severe cases. Bioinformatics. 2021; 37(17):2691-2698. PMC: 7989618. DOI: 10.1093/bioinformatics/btab163. View

19.

Gottlieb A, Stein G, Ruppin E, Sharan R . PREDICT: a method for inferring novel drug indications with application to personalized medicine. Mol Syst Biol. 2011; 7:496. PMC: 3159979. DOI: 10.1038/msb.2011.26. View

20.

Lu C, Yang M, Luo F, Wu F, Li M, Pan Y . Prediction of lncRNA-disease associations based on inductive matrix completion. Bioinformatics. 2018; 34(19):3357-3364. DOI: 10.1093/bioinformatics/bty327. View